News & Events

BD Biosciences, a segment of BD (Becton, Dickinson and Company), today announced the five winners of its 2007 Research Grant Program who will receive individual grants of research reagents valued at a total of $125,000 to conduct innovative research projects.

“We are honored to play a part in sponsoring the research that may one day have a profound impact on human health,” said Robert Balderas, Vice President of Biological Sciences, BD Biosciences. “We hope that by supporting the work of promising scientists, we help to engender the next wave of breakthrough research.”

More than 400 researchers submitted abstracts for consideration. Winners were determined by an independent panel of distinguished scientific experts.

“The caliber of abstracts submitted this year was outstanding,” said Jonni S. Moore, Ph.D., member of the BD Biosciences Research Grant Program judging panel and Professor of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine. "They illustrated the diversity, quality and sophistication of life sciences research taking place in laboratories across the United States. These investigations will do much to further our understanding of human health and have the promise of leading to critical breakthroughs in clinical medicine.”

The following recipients will be awarded individual $25,000 grants of research reagents:

• Olga Danilova
  Tufts University School of Medicine
  Abstract title: A New Prognostic Factor and Potential Treatment of Chronic Lymphocytic Leukemia (CLL)
  
  
• Yihong Wan
  The Salk Institute
  Abstract title: Identification of Osteoclast Progenitor Cells
  
  
• Duane Jeansonne
  University of Texas Health Science Center at San Antonio
  Abstract title: The Role of Plasmacytoid Dendritic Cells
  
  
• Lisa Ganley-Leal
  Boston University School of Medicine
  Abstract title: B cell Alternative Receptors
  
  
• Ying Liang
  University of Kentucky
  Abstract title: Latexin: A New Tumor Suppressor

  Additional information on the winning submissions, including the full abstracts, is available at http://www.bdbiosciences.com/grant.

  About the BD Biosciences Research Grant Program

  BD Biosciences’ Research Grant Program aims to reward and enable important research by providing vital funding for scientists pursuing innovative experiments to advance the scientific understanding of disease. The grant submissions are judged by a distinguished research panel of non-affiliated scientists. Through its grant program, BD works to support innovation in research and development as well as help define the next generation of scientific breakthroughs.

  About BD
  
  BD, a leading global medical technology company that manufactures and sells medical devices, instruments and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit, www.bd.com.

  ###